a) Bioconversions with 0.5 gCDW L-1 of cells in Erlenmeyer flasks, 10 min assay time
b) Addition of 9.2 mM cyclohexane (180 µM in aqueous phase), activities correspond to the first 10 min in the experiments shown in Figures 3BD, 4B, S3B.
c) Maximal activity obtained by testing different cyclohexanol concentrations (see also Figure 3F)
d) Addition of 5 mM substrate
e) Average values for the sum of ε-CL and 6HA formed including standard deviations of two independent biological replicates.
Table 3: Comparison of biocatalytic PCL precursor synthesis approaches.